Tanya Simuni

机构：Northwestern University

发表论文 319 篇 · 总被引 17381 次 · h-index 65

代表论文

• Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial (2024 · Nature Medicine · 被引 57)
• Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts (2024 · npj Parkinson s Disease · 被引 40)
• Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use (2025 · Science Advances · 被引 19)
• LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization (2025 · Brain Communications · 被引 19)
• Accelerating Parkinson’s Disease drug development with federated learning approaches (2024 · npj Parkinson s Disease · 被引 19)
• Neuronal α‐Synuclein Disease Stage Progression over 5 Years (2025 · Movement Disorders · 被引 17)